2022-02-07 - Cancer Synoptic Reporting Project Group Meeting

1

IHC

Scott Campbell

1. Focus on synoptic reporting uses.

2. Examples:

   1. Breast cancer her2 from breast tissue (typical scenario)

   2. breast cancer her2 from lymph node (metastatic scenario)

Note: This defers metastatic observable to the info model

a. her2 in breast tissue

Open

b. her2 in breast cancer from lymph node

Open

2

Treatment effect

Scott Campbell

Continue discussion:

What are we measuring when assessing "treatment effect"?  

Is this a histologic change?  Viability of tumor cells?

1. Primary site

2. Lymph node

Note: SSA wonders about property in this model

1. Primary site

   Open

   

   
   
   
   

2. Lymph node

Open

Will review model.  This observable pertains to the process of regression/change in the neoplasm after antineoplastic therapy.  So, observable could be modeled as presence of process changes.

3

Lymph nodes

Scott Campbell

Stefan Dubois (Unlicensed)

1. Discuss approach to lymph node body structures and differences in naming/locations (example AJCC esophageal cancer vs. JES esophageal cancer)

2. Management of observables for lymph node involvement.  Example: 

Did not discuss

4

AJCC update?

Jim Case

Any updates that can be shared?

Jim Case meeting with AJCC on Wednesday 26-Jan to continue/finalize contract issues